Portfolio company
TRANSURETHRAL IMAGING & THERAPY
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
Exact Imaging
This company develops high-resolution micro-ultrasound systems for urologists to perform real-time imaging and guided biopsies for prostate cancer detection.
PCaVision
This company develops artificial intelligence software that analyses ultrasound recordings to assist urologists with prostate cancer diagnosis and biopsy planning for clinical patients.
UTERINE FIBROID TREATMENT
This medical technology company develops a minimally invasive, uterus-sparing radiofrequency ablation system for women suffering from symptomatic uterine fibroids.
Active Needle
This company develops ultrasonic needle actuation devices for clinicians to improve visibility and precision during ultrasound-guided interventional procedures such as biopsies and drug delivery.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
Koelis
Koelis develops ultrasound image-guided systems for prostate cancer diagnosis and treatment, providing MRI-fusion technology and focal therapy solutions to urologists and clinics.
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
